Neuroblastoma-targeted Anticancer Drug Delivery
Neuroblastoma (NB) is the most common solid tumor in pediatric cases. NB accounts for about 8% of malignancies in patients younger than 15 years, and since 50% of newly diagnosed cases metastasize to regional lymph nodes, bone marrow, bone, liver, and skin, the disease is usually diagnosed in its la...
Saved in:
Main Authors: | Safiye Aktaş (Author), Özde Elif Gökbayrak (Author), Aylin Erol (Author), Hatice Nur Olgun (Author) |
---|---|
Format: | Book |
Published: |
Galenos Publishing House,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular Heterogeneity in Neuroblastoma and Its Clinical Significance
by: Tekincan Çağrı Aktaş, et al.
Published: (2023) -
Neuroblastoma and Hippo Signaling Pathway
by: Selen Kum Özşengezer, et al.
Published: (2021) -
The Significance of Histopathologic Assessment in Bone Marrow Disease in Neuroblastoma
by: Sumeyye EKMEKCI, et al.
Published: (2022) -
Advanced and Innovative Nano-Systems for Anticancer Targeted Drug Delivery
by: Lu Tang, et al.
Published: (2021) -
Targeting autophagy in neuroblastoma
by: Siqi Huang, et al.
Published: (2020)